ADVANCED PROSTATE CANCER
Clinical trials for ADVANCED PROSTATE CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PROSTATE CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PROSTATE CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Two-Pronged attack on advanced prostate cancer begins human testing
Disease control Recruiting nowThis early-stage study is testing the safety and side effects of a new two-drug combination for men with advanced prostate cancer that has stopped responding to standard hormone therapy. The trial combines an antibody-drug (HS-20093) that targets cancer cells with a second drug (…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Hansoh BioMedical R&D Company • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Double-Drug attack on advanced prostate cancer begins human testing
Disease control Recruiting nowThis early-stage trial is testing a new two-drug combination for men with advanced prostate cancer that has spread. The main goal is to find safe dose levels and check for side effects. Researchers will also look for early signs that the treatment might help control the cancer.
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
New hope for Tough-to-Treat prostate cancer in early trial
Disease control Recruiting nowThis is an early-stage study to test the safety and side effects of a new drug, RO7656594, in men with advanced or metastatic prostate cancer that has progressed after standard treatments. The main goals are to find a safe dose and see how the body processes the drug. Researchers…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
Five sessions instead of weeks: new prostate cancer radiation trial
Disease control Recruiting nowThis study is testing a shorter, more intense form of radiation therapy for men with advanced prostate cancer. Instead of receiving radiation over several weeks, participants get just five high-dose sessions. The main goals are to see how safe this approach is and how it affects …
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
New scan aims to spot elusive prostate cancer
Diagnosis Recruiting nowThis study is testing a new type of PET scan to see if it can better detect aggressive forms of advanced prostate cancer that are difficult to find with current standard scans. Researchers will enroll about 30 men with this specific type of cancer to compare the new scan against …
Matched conditions: ADVANCED PROSTATE CANCER
Phase: PHASE1 • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated Mar 23, 2026 15:16 UTC
-
Virtual therapy trial aims to ease the heavy burden of advanced cancer
Symptom relief Recruiting nowThis study is testing a new telehealth counseling program called ENGAGE, designed to help people with advanced cancer better manage their symptoms. It will compare ENGAGE to standard supportive care in 190 patients with Stage IV breast, prostate, lung, or colorectal cancer. The m…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated Mar 24, 2026 12:01 UTC
-
New scan combo could map prostate Cancer's secrets
Knowledge-focused Recruiting nowThis study aims to learn more about advanced prostate cancer by using two different types of PET scans on the same patients. Researchers want to see how the cancer looks at different stages and during treatment. This information could help doctors choose better treatments and mon…
Matched conditions: ADVANCED PROSTATE CANCER
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:27 UTC